Supplementary figure S13 from Tumor Cell–Intrinsic Decr2 Regulates Ferroptosis and Immunotherapy Efficacy

Key Points

• MAIN FINDING: Decr2 knock-down in tumor cells decreases phospholipid levels.
• KEY EVIDENCE: The study highlights decreased polyunsaturated ether phospholipids in these cells.
• APPROACH: Analysis of supplementary figure S13 reveals the biochemical impact of Decr2 knock-down.
• SIGNIFICANCE: Understanding Decr2's role can enhance strategies for immunotherapy targeting ferroptosis.